Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.
- DOI
- 10.1038/s41375-019-0575-9
- Published
- 2019 Nov
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-019-0575-9,
title = {Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.},
author = {Wang M and Rule S and Zinzani PL and Goy A and Casasnovas O and Smith SD and Damaj G and Doorduijn JK and Lamy T and Morschhauser F and Panizo C and Shah B and Davies A and Eek R and Dupuis J and Jacobsen E and Kater AP and Le Gouill S and Oberic L and Robak T and Jain P and Frigault MM and Izumi R and Nguyen D and Patel P and Yin M and Długosz-Danecka M},
year = {2019},
journal = {Leukemia},
doi = {10.1038/s41375-019-0575-9},
url = {https://doi.org/10.1038/s41375-019-0575-9}
}RIS
TY - JOUR TI - Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma. AU - Wang M AU - Rule S AU - Zinzani PL AU - Goy A AU - Casasnovas O AU - Smith SD AU - Damaj G AU - Doorduijn JK AU - Lamy T AU - Morschhauser F AU - Panizo C AU - Shah B AU - Davies A AU - Eek R AU - Dupuis J AU - Jacobsen E AU - Kater AP AU - Le Gouill S AU - Oberic L AU - Robak T AU - Jain P AU - Frigault MM AU - Izumi R AU - Nguyen D AU - Patel P AU - Yin M AU - Długosz-Danecka M PY - 2019 JO - Leukemia DO - 10.1038/s41375-019-0575-9 UR - https://doi.org/10.1038/s41375-019-0575-9 ER -
APA
M, W., S, R., PL, Z., A, G., O, C., SD, S., G, D., JK, D., T, L., F, M., C, P., B, S., A, D., R, E., J, D., E, J., AP, K., S, L. G., L, O., T, R., P, J., MM, F., R, I., D, N., P, P., M, Y., & M, D. (2019). Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.. Leukemia. https://doi.org/10.1038/s41375-019-0575-9
Source records
- pubmed · retrieved 2026-09-26T06:43:52.605Z